Another interesting study found that increased doses of APP markedly decrease retrograde transport of nerve growth factor (NGF) and causes degeneration of forebrain cholinergic neurons in a mouse model of Down's Syndrome (DS) [16]. The gene discussed is NGF; the disease is Down syndrome.